136 related articles for article (PubMed ID: 9044031)
1. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
Braga PC; Dal Sasso M; Maci S
J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
3. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Braga PC; Sasso MD; Sala MT
J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of bacterial adhesion by sub-inhibitory concentrations: brodimoprim vs trimethoprim.
Braga PC; Piatti G; Limoli A; Santoro M; Gazzola T
J Chemother; 1993 Dec; 5(6):447-52. PubMed ID: 8195836
[TBL] [Abstract][Full Text] [Related]
5. [Effect of sub-inhibitory concentrations of cefixime on the morphology, hemagglutination and adhesiveness of urinary strains of Escherichia coli].
Desnottes JF; Diallo N; Loubeyre C
Presse Med; 1989 Oct; 18(32):1572-5. PubMed ID: 2530535
[TBL] [Abstract][Full Text] [Related]
6. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Murgia R; Marchetti F; Cinco M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
[TBL] [Abstract][Full Text] [Related]
7. Influence of enoxacin sub-MICs on the adherence of Staphylococcus aureus and Escherichia coli to human buccal and urinary epithelial cells.
Braga PC; Piatti G
Chemotherapy; 1992; 38(4):261-6. PubMed ID: 1473365
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Willke A; Tural D
Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus and Escherichia coli adhesion to human cells is reduced by sub-MICs of gemifloxacin.
Braga PC; Dal SM; Woodnutt G
J Chemother; 2002 Feb; 14(1):41-6. PubMed ID: 11892898
[TBL] [Abstract][Full Text] [Related]
10. Sub-minimum inhibitory concentrations of ceftibuten reduce adherence of Escherichia coli to human cells and induces formation of long filaments.
Braga PC; Piatti G
Microbiol Immunol; 1993; 37(3):175-9. PubMed ID: 8321147
[TBL] [Abstract][Full Text] [Related]
11. Favourable effects of sub-MIC rufloxacin concentrations in decreasing the pathogen-host cell adhesion.
Braga PC; Piatti G
Pharmacol Res; 1993; 28(1):11-9. PubMed ID: 8234142
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Wenisch C; Bartunek A; Zedtwitz-Liebenstein K; Hiesmayr M; Parschalk B; Pernerstorfer T; Graninger W
Antimicrob Agents Chemother; 1997 Jul; 41(7):1584-8. PubMed ID: 9210690
[TBL] [Abstract][Full Text] [Related]
13. [Influence of protein binding on the antibacterial effects of 2 cephalosporins].
Meinardi G; Grasso S; de Carneri I
G Ital Chemioter; 1985; 32(2):343-6. PubMed ID: 3869113
[No Abstract] [Full Text] [Related]
14. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
[TBL] [Abstract][Full Text] [Related]
15. Effects of sub-minimum inhibitory concentrations of gatifloxacin on the inhibition of Staphylococcus aureus and Escherichia coli adherence.
Braga PC; Dal Sasso M
Arzneimittelforschung; 2002; 52(2):109-12. PubMed ID: 11878198
[TBL] [Abstract][Full Text] [Related]
16. Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime.
Braga PC; Ricci D
Antimicrob Agents Chemother; 1998 Jan; 42(1):18-22. PubMed ID: 9449254
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity and beta-lactamase stability of cefodizime, a new cephalosporin antibiotic.
Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
Jpn J Antibiot; 1984 Jul; 37(7):1294-305. PubMed ID: 6092739
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
Ruczkowska J; Dolna I
Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory and bactericidal activity of cefpirome and cefotaxime against blood culture isolates.
Ansorg R; Primavesi CA; von Recklinghausen G
Chemotherapy; 1990; 36(1):24-8. PubMed ID: 2106417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
